Grand Challenges on HIV/AIDS in China – The 5th Symposium, Yunnan 2024
HIV-1 infection has led to 1.329 million people living with the virus and 0.474 millions of deaths by the middle of 2024 in China. Achieving the goal of ending HIV/AIDS in China by 2030 has faced several grand challenges including currently having a diagnostic rate of less than 85%, an estimated annual cost burden of 6.3 billion RMB for antiretroviral therapy (ART) alone, and the lack of therapeutic cure and preventive vaccine and so on. To address these challenges, Chinese scientists initiated the programme of <i>Grand Challenges on HIV/AIDS in China</i> (GCC) in 2017. The inauguration symposium was held from 30 November to 1 December 2017 in Hong Kong - Asia's World City - to commemorate the 10th anniversary of AIDS Institute at The University of Hong Kong and Comprehensive AIDS Research Center at Tsinghua University. The mission of the GCC is to advance HIV/AIDS prevention, prioritize research on therapeutic cure and vaccine, disseminate new scientific findings, and foster broader collaborations. Following the inaugural event, subsequent symposia were held at Fudan University in 2018, Sun Yat-Sen University in 2019, Tsinghua University in 2023, and Dali University in 2024. This review reports the scientific presentations and progresses made by the GCC scientists, highlighting efforts to combat HIV/AIDS in China.
Authors
- Linghua Li (ORCID: https://orcid.org/0000-0001-5711-8681)
- Jianqing Xu (ORCID: https://orcid.org/0000-0003-0896-9273)
- Linqi Zhang (ORCID: https://orcid.org/0000-0003-4931-509X)
- Faming Wang (ORCID: https://orcid.org/0000-0002-7543-6779)
- Kai Deng (ORCID: https://orcid.org/0000-0002-9973-8130)
- Hao Wu (ORCID: https://orcid.org/0000-0001-9552-3178)
- Jinghe Huang (ORCID: https://orcid.org/0000-0002-1968-871X)
- Zhiwei Wu (ORCID: https://orcid.org/0000-0002-0672-948X)
- Hui Zhang (ORCID: https://orcid.org/0000-0003-3620-610X)
- Ling Chen (ORCID: https://orcid.org/0000-0003-1485-1626)
- Jian‐Hua Wang (ORCID: https://orcid.org/0000-0002-6435-9907)
- Zhiwei Chen (ORCID: https://orcid.org/0000-0002-5994-3922)
- Xia Jin
- Weiping Cai (ORCID: https://orcid.org/0000-0002-4515-6098)
- Hong Shang
Institutions
- Capital University (US)
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- Fudan University (CN)
- Hong Kong Science and Technology Parks Corporation (HK)
- Guangzhou Institutes of Biomedicine and Health (CN)
- Chinese PLA General Hospital (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Shenzhen Bay Laboratory (CN)
- Shanghai Public Health Clinical Center (CN)
- Tsinghua–Berkeley Shenzhen Institute (CN)
- Institute of Human Virology (NG)
- National Clinical Research (US)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- First Hospital of China Medical University (CN)
- Beijing YouAn Hospital (CN)
- Guangzhou Eighth People's Hospital (CN)
- PLA Academy of Military Science (CN)
- Dali University (CN)
- University of Hong Kong (HK)
- Guangzhou Medical University (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Emerging Microbes & Infections
- Published
- 2025-04-09
- DOI
- https://doi.org/10.1080/22221751.2025.2492208
- Citations
- 5
- Primary Topic
- HIV/AIDS Research and Interventions
- Type
- article
- Field-Weighted Citation Impact
- 6.98